fda warning peptides bpc-157 not approved safety unapproved fda bpc-157 peptide approved bpc-157 FDA panel narrowly backs unapproved

Oral vitamin B12 replacement: an effective treatment for vitamin B12 deficiency after total gastrectomy in gastric cancer patients

Unreconstituted (lyophilized/powder) retatrutide is considerably more stable

Applications received for the later deadlines for the remaining 2025 quarters (the quarters beginning June 1, September 1, and December 1 of 2025), if any, will be discussed in the CY 2027 OPPS/ASC proposed rule

Immediate effects: Many report boosts in energy and focus within days

What we know about glycine: Peer-reviewed research confirms that glycine activates mTORC1 signaling, protects muscle cells from wasting, accelerates fat loss during caloric restriction, and has anti-inflammatory properties

After consideration of public comments, for CY 2026, we are finalizing the proposed lists of qualifying products and payment limitations, with modifications